Back to UBS Group AG UBS Group AG

SBFMSBFM
18 quarters

Position history for UBS Group AGUBS Group AG's holdings in SUNSHINE BIOPHARMA INC

UBS Group AG previously held 0 shares of SBFM (SUNSHINE BIOPHARMA INC), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$6,000

Total Shares Change

-2,434

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$2.10
0
2026-Q1
Decreased
1,103
-41.1%
$1,1470.0%$1.14
0
2025-Q4
Increased
1,873
+809.2%
$2,3030.0%$1.23
13
2025-Q3
Unchanged
206
0.0%
$3070.0%$1.45
0
2025-Q2
Decreased
206
-99.0%
$2970.0%$1.46
0
2025-Q1
Increased
19,885
+2190.9%
$37,9800.0%$2.00
22
2024-Q4
New
868
-
$2,6040.0%$2.81
19
2024-Q3
Exited
0
-100.0%
$00.0%$3.20
0
2024-Q2
Unchanged
1
0.0%
$00.0%$8.36
0
2024-Q1
Decreased
1
-100.0%
$00.0%$122.00
0
2023-Q4
Increased
2,201
+2200x
$5980.0%$544.00
12
2023-Q3
Unchanged
1
0.0%
$00.0%$640.00
0
2023-Q2
Decreased
1
-100.0%
$00.0%$972.00
0
2023-Q1
Decreased
2,407
-66.6%
$1,7600.0%$1,456.00
0
2022-Q4
Increased
7,210
+7209x
$4,6150.0%$1,280.00
16
2022-Q3
Unchanged
1
0.0%
$00.0%$1,540.00
0
2022-Q2
Decreased
1
-100.0%
$00.0%$2,180.00
0
2022-Q1
New
2,434
-
$6,0000.0%$4,760.00
24

Other major holders of SBFM: Hudson Bay Capital Management LP, RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used